Ivane Gamkrelidze

4 ta ish

Center for Disease Analysis

1. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

   Sarah Blach, Norah A. Terrault, Frank Tacke +97

   Sharh maqolaOAOchiq kirish20224 iqtibos

   ABIABI:AkademIndex/2026.other.117938

2. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

   Devin Razavi‐Shearer, Ivane Gamkrelidze, Calvin Q. Pan +97

   Maqola20234 iqtibos

   ABIABI:AkademIndex/2026.other.419454

3. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

   Sarah Blach, Stefan Zeuzem, Michael P. Manns +97

   Sharh maqola20164 iqtibos

   ABIABI:AkademIndex/2026.other.501010

4. Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies

   Homie Razavi, Imam Waked, Huma Qureshi +97

   MaqolaOAOchiq kirishHepatitis C virus researchJournal of Hepatology20250 iqtibos

   ABIABI:AkademIndex/2025.article.000135